TFX
$339.62
Teleflex
($.80)
(.24%)
TFX
Earnings Whisper ®
N/A
3rd Quarter September 2020
Consensus:  $2.28
Revenue:  $624.64 Mil
Thursday
Oct 29
6:30 AM ET
Score
Grade
Tweet Share Watch
Tweet Share Watch
Latest EPS
Thursday, July 30, 2020

What do you expect when TFX reports earnings?
Beat
Meet
Miss

Where is TFX's stock price going from here?
Up
Flat
Down
Stock chart of TFX
Analysts
Summary of analysts' recommendations for TFX
Score
Grade
Pivots
Resistance
$352.35
$348.45
$344.43

$340.53

Support
$336.51
$332.61
$328.59
Tweet
Growth
Description
Teleflex Inc. designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. The company offers its products to hospitals and healthcare providers through its direct sales force and distributors. Teleflex was founded in 1943 and is headquartered in Wayne, Pennsylvania.
Peers
StrykerBoston ScientificBaxter InternationalBecton, DickinsonAbbottWatersIntegra LifeSciences HoldingsCardiovascular Systems3MResMed